publications-2011-2013

Novel ET02-GL1S2 fusion and therapeutic strategy in acute megakaryoblastic leukemia

Published on 19 March 2015

Novel ET02-GL1S2 fusion and therapeutic strategy in acute megakaryoblastic leukemia
Authors	Thiollier C, Pflumio F, Ballerini P, Crispino JD, Bernard O, Mercher T
Journal	M S-Med. Sci. 28 (11), 1013-1016, 2012
Year	2012
Institute	iRCM

Retour à la liste

Top page

Alternative and Atomic Energies Agency

CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.

The Knowledge Factory

In the same section :

Novel ET02-GL1S2 fusion and therapeutic strategy in acute megakaryoblastic leukemia

Browse the site

Alternative and Atomic Energies Agency

Browse the portal

The Knowledge Factory

About Fundamental Research Division

Research fields

Scientific results

In the same section :

Novel ET02-GL1S2 fusion and therapeutic strategy in acute megakaryoblastic leukemia

Browse the site

Alternative and Atomic Energies Agency

Browse the portal